The Prospective Observational Study Evaluating the Clinical Profile and Correlation of Subjective and Objective Parameters of GERD in a Tertiary Care Hospital : An Indian Perspective

November 1, 2026 updated by: Mohan Ramchandani, Asian Institute of Gastroenterology, India

This prospective, single-center study at AIG Hospitals, Hyderabad, aims to establish normal 24-hour ambulatory esophageal pH-impedance values, including acid exposure time (AET), in 50 healthy Indian adults. Current Western diagnostic cut-offs may not be applicable to the Indian population, where normal AET is likely lower. Healthy volunteers aged 18-50 with no GI symptoms or systemic diseases will undergo baseline evaluations, high-resolution manometry, and 24-hour pH-impedance monitoring while maintaining regular activities. The study will assess how diet, body position, and sleep affect reflux, with statistical analysis to determine normative values for improved GERD diagnosis in India.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Telangana
      • Hyderabad, Telangana, India, 500032
        • AIG hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 4 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

This study will include adults aged 18-50 years with GERD symptoms

Description

Inclusion Criteria:

Age ≥18 years.

Symptoms of GERD (heartburn, regurgitation, chest pain) diagnosed using:

Clinical symptoms based on validated questionnaires. Endoscopic findings (e.g., esophagitis, Barrett's esophagus). Provide written informed consent.

Exclusion Criteria:

Pregnant women or breast-feeding women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
This study will include a cohort of adults aged 18-50 years with GERD symptoms

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To correlate the subjective (GERD HRQL scores) and objective (Endoscopy, Esophageal manometry and 24-hour pH- impedance monitoring) parameters of GERD
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
To develop predective models for forecasting manometric and pH findings
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2026

Primary Completion (Actual)

August 1, 2026

Study Completion (Actual)

August 8, 2026

Study Registration Dates

First Submitted

November 1, 2026

First Submitted That Met QC Criteria

November 1, 2026

First Posted (Actual)

November 5, 2026

Study Record Updates

Last Update Posted (Actual)

November 5, 2026

Last Update Submitted That Met QC Criteria

November 1, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • GERDCR-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.